Vela said that the Sentosa SQ HIV genotyping assay delivers clinical results with reduced hands-on and turnaround time compared to competitors.
The CE-marked test enables health professionals to distinguish between HIV-1 and HIV-2, and runs on the fully automated Cobas 6800/8800 systems.
An OpenArray panel designed to simultaneously test for 17 viruses and 13 bacteria and protozoa was able to detect pathogens from human blood donor samples with an accuracy of about 95 percent.
In PLOS this week: root-knot nematode sequencing study, somatic mutations linked to uveal melanoma, and more.
After putting off his doctoral studies to find rock-and-roll fame, the Offpring's Dexter Holland graduated this week with a Ph.D. in molecular biology from USC.
The firm said that prior to obtaining US regulatory clearance, it's making the assay available for use as a lab-developed test by US laboratories with CLIA approvals.
Researchers sequenced and analyzed 169 Mycobacterium tuberculosis strains from people with and without HIV infections.
The firm will apply its qPCR-enabling technology to detection kits for highly polymorphic regions of HIV that confer resistance to protease inhibitors.
In Cell this week: strategies for targeting leukemia with MLL translocations, new Perturb-seq approach, and more.
Mathais Lichterfeld of the Ragon Institute and Rushdy Ahmad of the Broad Institute will use high-throughput proteomics to find phosphorylation important to HIV replication.
The ancestors of the Arizona bark scorpion and other scorpions and spiders underwent whole-genome duplication, KJZZ reports.
A cryptographic approach could help researchers keep genomic data private while researchers analyze it, Scientific American reports.
Andy Page, the former president of 23andMe, has joined a diabetes-management startup, according to CNBC.
In Cell this week: regulatory changes in pancreatic cancer, metabolic shifts in Alzheimer's disease, and more.